The study, led by ISGlobal — a centre supported by the «la Caixa» Foundation — and published in Scientific Reports, indicates that this enzyme could represent
a selective therapeutic target against this broad group of parasites.
Together, these data indicate that MELK is a normally non-essential kinase, but is critical for BBC and thus represents a promising
selective therapeutic target for the most aggressive subtype of breast cancer.
Not exact matches
«Because of its different origin, this enzyme could represent a good
therapeutic target with
selective action against all apicomplexans,» adds Luis Izquierdo, ISGlobal researcher and coordinator of the study.
Examination of such mechanisms by which the brain naturally protects itself may lead to more
selective cellular and molecular
targets, as well as new
therapeutic strategies against brain disease.